First Postpartum Depression Drug Approved by FDA Could Cost up to $35,000 for 1 Treatment — KTLA

For the first time in history, the US Food and Drug Administration has approved a drug specifically indicated for the treatment of postpartum depression, which experts say offers new hope to women and physicians. On Tuesday, the FDA announced the approval of an intravenous infusion of the drug brexanolone, which will be sold as Zulresso. It…

via First Postpartum Depression Drug Approved by FDA Could Cost up to $35,000 for 1 Treatment — KTLA